Rilmenidine extends lifespan and healthspan in<i> Caenorhabditis</i><i> elegans</i> via a nischarin I1-imidazoline receptor



Bennett, Dominic F, Goyala, Anita, Statzer, Cyril, Beckett, Charles W, Tyshkovskiy, Alexander, Gladyshev, Vadim N, Ewald, Collin Y and de Magalhaes, Joao Pedro ORCID: 0000-0002-6363-2465
(2023) Rilmenidine extends lifespan and healthspan in<i> Caenorhabditis</i><i> elegans</i> via a nischarin I1-imidazoline receptor. AGING CELL, 22 (2). e13774-.

Access the full-text of this item by clicking on the Open Access link.
[img] Text
Rilmenidine extends lifespan and healthspan in Caenorhabditis elegans via a nischarin I1-imidazoline receptor.pdf - Open Access published version

Download (4MB) | Preview

Abstract

Repurposing drugs capable of extending lifespan and health span has a huge untapped potential in translational geroscience. Here, we searched for known compounds that elicit a similar gene expression signature to caloric restriction and identified rilmenidine, an I1-imidazoline receptor agonist and prescription medication for the treatment of hypertension. We then show that treating Caenorhabditis elegans with rilmenidine at young and older ages increases lifespan. We also demonstrate that the stress-resilience, health span, and lifespan benefits of rilmenidine treatment in C. elegans are mediated by the I1-imidazoline receptor nish-1, implicating this receptor as a potential longevity target. Consistent with the shared caloric-restriction-mimicking gene signature, supplementing rilmenidine to calorically restricted C. elegans, genetic reduction of TORC1 function, or rapamycin treatment did not further increase lifespan. The rilmenidine-induced longevity required the transcription factors FOXO/DAF-16 and NRF1,2,3/SKN-1. Furthermore, we find that autophagy, but not AMPK signaling, was needed for rilmenidine-induced longevity. Moreover, transcriptional changes similar to caloric restriction were observed in liver and kidney tissues in mice treated with rilmenidine. Together, these results reveal a geroprotective and potential caloric restriction mimetic effect by rilmenidine that warrant fresh lines of inquiry into this compound.

Item Type: Article
Uncontrolled Keywords: aging, autophagy, drug repurposing, longevity, mTOR, nischarin receptor
Divisions: Faculty of Health and Life Sciences
Faculty of Health and Life Sciences > Institute of Life Courses and Medical Sciences
Depositing User: Symplectic Admin
Date Deposited: 17 May 2023 14:58
Last Modified: 17 Oct 2023 22:35
DOI: 10.1111/acel.13774
Open Access URL: https://doi.org/10.1111/acel.13774
Related URLs:
URI: https://livrepository.liverpool.ac.uk/id/eprint/3170453